Additionally, SAMHD1 was only recently identified as a potential novel driver gene in MCL, with missense or deletion mutations in SAMHD1 being present in 10% of patients from the analyzed MCL cohort [88]. This evidence concerns the gene SAMHD1 and mantle cell lymphoma.